YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection.
OTK18 is a C2H2 type zinc finger protein involved in the regulation of HIV-1 replication in human mononuclear phagocytes. Previously, we reported OTK18 expression in brain perivascular macrophages but not in microglia in HIV encephalitis brain. We have cloned the OTK18 promoter region proximal to the transcriptional start site and determined the region responsible (-884/+1) for the basal transcriptional activity in a microglia cell line. Sequential deletion mutation analyses reveal three important response elements: Yingyang-1 (YY1; -805/-777), an HIV-1 response element for promoter activation; FoxD3 (-743/-725), a negative regulatory element; and Ets response element (-725/-707), a basal transcriptional activity response element. HIV-1 infection-induced upregulation of YY1 and c-Ets-1 protein, binding to the promoter region as determined by immunoblotting and chromatin immunoprecipitation and polymerase chain reaction (PCR) assays, and induction of YY1 was also observed in virus-infected monocyte-derived macrophages. Silencing of FoxD3 and YY1 in the cell line by small interfering RNA duplexes specific to these molecules significantly up- and downregulated basal OTK18 promoter activity in FoxD3 and YY1 response element-dependent manners, respectively. On the other hand, infection of primary cultured human microglia significantly reduced YY1 expression and induced FoxD3 as determined by immunoblotting and reverse transcription real-time PCR. These data suggest that HIV-1 induces OTK18 expression through a YY1-mediated manner in human macrophages, although its gene expression is suppressed by FoxD3 upregulation and YY1 downregulation in human microglia. This mechanism may explain the perivascular macrophage-specific expression of OTK18 in HIV encephalitis brains.
Buescher
James L
JL
Department of Pharmacology and Experimental Neuroscience, Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Martinez
Lindsey B
LB
Sato
Shinji
S
Okuyama
Satoshi
S
Ikezu
Tsuneya
T
D024506:5' Flanking Region / Q000235:genetics; D015153:Blotting, Western; D047369:Chromatin Immunoprecipitation; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics*; D051858:Forkhead Transcription Factors / Q000502:physiology*; D005786:Gene Expression Regulation; D015658:HIV Infections / Q000378:metabolism*; D015497:HIV-1; D006801:Humans; D008156:Luciferases / Q000235:genetics; D008264:Macrophages / Q000378:metabolism; D017628:Microglia / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics* / Q000502:physiology*; D050784:Proto-Oncogene Protein c-ets-1 / Q000502:physiology; D034741:RNA, Small Interfering / Q000235:genetics; D050436:Regulatory Elements, Transcriptional / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics*; D014162:Transfection; D050986:YY1 Transcription Factor / Q000502:physiology*
D004268:DNA-Binding Proteins; C503514:FOXD3 protein, human; D051858:Forkhead Transcription Factors; D050784:Proto-Oncogene Protein c-ets-1; D034741:RNA, Small Interfering; D014157:Transcription Factors; D050986:YY1 Transcription Factor; C494698:YY1 protein, human; C104178:ZNF175 protein, human; D008156:Luciferases